Quantcast

Latest Compression fracture Stories

2011-05-24 09:50:00

SAN JOSE, Calif., May 24, 2011 /PRNewswire/ -- DFINE, Inc., the developer of minimally invasive radio frequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced two new product enhancements to its StabiliT® Vertebral Augmentation System - the most advanced treatment option for vertebral compression fractures (VCFs). Designed to improve the physician experience and provide greater flexibility and ease-of-use for the minimally invasive...

2011-05-11 07:37:32

(Ivanhoe Newswire) -- One in 10 heart failure patients had compression fractures in the spine that could have been detected by a chest X-ray, but few are receiving treatment to help prevent such fractures. Among 623 heart failure patients, researchers found that 12 percent had moderate to severe vertebral compression fractures and 55 percent of those had multiple fractures. These fractures are a sign of osteoporosis, a condition in which bones become less dense and have a high risk of...

2011-04-18 07:00:00

SANTA CLARA, Calif., April 18, 2011 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced the completion of a $35.5 million Series C round of financing. The proceeds will be used to complete KAST (Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) and execute on the company's commercialization strategy. Benvenue Medical is entering a $9 billion global spinal device market with...

2011-03-29 12:23:00

SANTA ROSA, Calif., March 29, 2011 /PRNewswire/ -- Osseon® Therapeutics announced today at the Society of Interventional Radiology's (SIR) Annual Meeting the launch of the Osseoflex BT Steerable Bone Tamp. The steerable bone tamp is designed to allow percutaneous access to sclerotic bone. The Osseoflex BT features the same proprietary technology found in the Osseoflex® Steerable Needle and Osseoflex® DR Steerable Drill. The Osseoflex...

2011-03-23 15:05:00

THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis. Adherence to treatment, which includes both compliance (a measure of how well patients follow directions for taking...

2010-11-29 13:00:00

DAYTON, Ohio, Nov. 29, 2010 /PRNewswire/ -- Results of a large-scale study, "Vertebroplasty vs. Conservative Treatment in Osteoporotic Vertebral Compression Fractures" (VERTOS II), provides Level 1 evidence that vertebroplasty helps relieve the pain caused by vertebral compression fractures at an acceptable cost.(1) The study also helps define the type of patient for whom the procedure is most suitable and effective.(1) Level 1 evidence refers to studies done under the strictest...

2010-11-10 09:07:00

In the news release, AAOS Clinical Guideline for Treating Spinal Compression Fractures Presents More Questions Than Answers for Medical Community, issued 09-Nov-2010 by Wayne J. Olan over PR Newswire, we are advised by the company that there were several updates made to the release. The complete, corrected release follows: AAOS Clinical Guideline for Treating Spinal Compression Fractures Presents More Questions Than Answers for Medical Community Dr. Wayne Olan evaluates findings; calls for...

2010-11-09 15:30:00

WASHINGTON, Nov. 9, 2010 /PRNewswire/ -- The clinical practice guideline recently issued by the American Academy of Orthopaedic Surgeons (AAOS) for treating spinal compression fractures has left the medical community scratching its head about what to tell patients. Spinal compression fractures (also called vertebral compression fractures or VCFS) are the most common complication of osteoporosis, a disease that affects an estimated 44 million Americans, or 55 percent of adults age 50 and...

2010-11-05 07:00:00

THOUSAND OAKS, Calif., Nov. 5, 2010 /PRNewswire/ -- Amgen (Nasdaq: AMGN) is pleased to announce that it has won the Best New Drug award for Prolia(TM) (denosumab), a novel treatment approved in the United States (U.S.) for women with postmenopausal osteoporosis at high risk for fracture, at the 2010 Scrip Awards ceremony Nov. 4 in London. Named one of TIME's Top 10 Medical Breakthroughs of 2009, Prolia is the first treatment specifically designed to target osteoclasts, the cells that break...

2010-10-14 16:01:00

THOUSAND OAKS, Calif., Oct. 14 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that results from several Prolia(TM) (denosumab) studies, as well as analyses of the growing global burden of osteoporosis, will be presented at the 2010 American Society for Bone and Mineral Research (ASBMR) annual meeting in Toronto, Ontario from Oct. 15-19, 2010. "The continued need to reduce fractures caused by postmenopausal osteoporosis is reinforced by data that will be presented at this year's...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related